Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ans.16457 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Curative Resection of Castleman Disease Initially Misdiagnosed as Gastrointestinal Stromal Tumor.
J Gastrointest Surg
March 2025
Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China. Electronic address:
[Incidentally discovered retroperitoneal unicentric Castleman disease during an ischemic colitis episode and diagnosed by computed tomography-guided needle biopsy: a case report].
Nihon Shokakibyo Gakkai Zasshi
March 2025
Department of Diagnostic Pathology, Kagawa Prefectural Central Hospital.
A 30-year-old female patient had an 8-cm retroperitoneal mass that was incidentally discovered during an abdominal computed tomography (CT) scan performed for diagnosing ischemic colitis, resulting in her referral to our hospital. A CT-guided needle biopsy was performed with a 20G needle, but the results were inconclusive. A 14G needle was used after weighing the benefits and harms, resulting in the diagnosis of a hyaline-vascular variant of Castleman disease.
View Article and Find Full Text PDFThis case describes a 46-year-old man presenting with epigastric pain, weight loss, and obstructive jaundice, initially misdiagnosed as pancreatic cancer due to a pancreatic head mass compressing the common bile duct. Intraoperative biopsies during an aborted Whipple procedure revealed coexisting autoimmune pancreatitis and Castleman disease. This case highlights the diagnostic challenges of Castleman disease, its potential association with autoimmune pancreatitis, and the critical role of histological analysis in differentiating it from malignancy.
View Article and Find Full Text PDFDesign, development, and evaluation of gene therapeutics specific to KSHV-associated diseases.
bioRxiv
February 2025
Department of Dermatology, School of Medicine, the University of California Davis (UC Davis), Sacramento, California, USA.
Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma (KS) and two human lymphoproliferative diseases: primary effusion lymphoma and AIDS-related multicentric Castleman's disease. KSHV-encoded latency-associated nuclear antigen (LANA) is expressed in KSHV-infected cancer cells and is responsible for maintaining viral genomes in infected cells. Thus, LANA is an attractive target for therapeutic intervention for KSHV-associated diseases.
View Article and Find Full Text PDFKSHVbook: An Information-Sharing Database for Kaposi's Sarcoma-Associated Herpesvirus.
J Med Virol
March 2025
Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, China.
Kaposi's sarcoma-associated herpesvirus (KSHV) is a double-stranded DNA virus belonging to the γ-herpesvirus subfamily. KSHV is the causative agent of Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), multicentric Castleman's disease (MCD), and KSHV inflammatory cytokine syndrome (KICS). Since its discovery, research on KSHV has rapidly progressed, but existing information platforms relatively lack comprehensiveness and do not provide efficient analysis tools tailored for KSHV.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!